Searched for
INVESTMENT IN US MANUFACTURING
Trump says tariffs won’t hurt US economy, claims levies will bring ‘hundreds of billions of dollars’ in investmentsPresident Donald Trump defended his tariff strategy, asserting it attracts hundreds of billions in investments. He stated these tariffs rep...- Trade gap seen as by-product of India's development stage, investment needs, energy dependence: Govt to ParliamentIndia's imports grew significantly, reflecting domestic demand and manufacturing expansion, the govt said. The trade deficit highlights dev...
- Warehousing investments jump 53% in H1; leasing rises 16%: VestianInstitutional investments in Indian warehousing rose 53 percent to USD 49 million. Leasing of industrial space increased 16 percent across ...
- US core capital goods orders climb 0.9% in June, beats expectationsU.S. manufacturing showed resilience in June with increased equipment investment. New orders for capital goods excluding aircraft rose sign...
- Tariff on generic drugs: Loud announcement, little consequence? 7 pharma stocks with upside potential of up to 31%The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...
- Explainer: Why investors are betting big on China’s chipmaker CXMTChina's ChangXin Memory Technologies (CXMT) became the country's most valuable listed company after its shares surged 470% on their Shangha...
- Pharma mutual funds top return charts across horizons. Should investors chase the rally or stay cautious?Pharma mutual funds are leading returns in CY2026, driven by strong earnings, defensive demand, and US export growth. Despite recent outper...
- US tariff proposal wake-up call for Indian pharma to diversify, innovate: ExpertsUS pharma tariffs: Experts have urged a shift towards global diversification and prioritising innovation for Indian pharma to lessen market...
- Confident of a 'breakout year' in FY 2027: Tata Technologies CEO & MD, Warren HarrisTata Technologies expects a significant growth year due to automotive manufacturers' increased investment. The company is securing full veh...
- White House report says US relies too heavily on foreign STEM talent, calls for stronger domestic pipelineA recent US report advocates for minimizing dependence on international STEM graduates for national security purposes. It highlights how Am...
- Cipla expects sequential recovery in North America on new product launches despite tariff uncertaintyCipla reported a 39% drop in net profit to ₹789 crore for the June quarter due to weakness in its North America business and margin compres...
- Tariffs alone will not produce sustainable generic medicine in US: IPAThe Indian Pharmaceutical Alliance believes tariffs alone will not build US generic drug manufacturing. Broader reforms are needed for fair...
- Generic drugmaker Sandoz to engage with US after Trump tariff threatUS President Donald Trump threatened steep tariffs on generic drugmakers. He stated medicines must be manufactured locally or face signific...
- Indian pharma firms may yet survive Trump's 200% tariff bombshellDonald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say...
- Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% stormTrump's generic drug tariffs plan provides Indian drugmakers a two-year duty-free window. This allows companies time to reassess manufactur...
- Trump's 200% drug tariff plan: Is India's pharma industry about to face an economic storm?The United States is set to implement a phased approach to tariffs on generic drug imports, beginning at zero percent and escalating to one...
- Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%For Indian exporters, the two-year tariff-free period offers additional time to reassess supply chains and investment plans. While the imme...
- Sun Pharma, Cipla & other pharma stocks shed over 2% as Trump announces up to 200% tariffs on generic drugs from 2028Pharma stocks, including Sun Pharma, Cipla, Lupin and Dr Reddy's, fell up to 2.5% after US President Donald Trump announced a phased tariff...
- Nvidia supplier Wistron launches $700 million Texas factory for AI system productionThe Fort Worth facility manufactures Nvidia's GB300 Grace Blackwell Ultra Superchip. Nvidia CEO Jensen Huang has described the AI system bu...
- TSMC pledges another $100 billion for US chip expansionTaiwan Semiconductor Manufacturing Company announced a significant new investment. The company plans to spend an additional one hundred bil...
Load More
